Gravity Analytica

T2 Biosystems to Report Third Quarter 2024 Financial Results and Business Updates on November 14, 2024

TTOO 11.05.2024

SERA-AI Powered Highlights

Date of Upcoming Event:2024-11-14

Name of Upcoming Event:earnings call

Full Press Release SEC Filings Our TTOO Tweets

About Gravity Analytica

Recent Filings

LEXINGTON, Mass.,Nov. 05, 2024(GLOBE NEWSWIRE) --T2 Biosystems, Inc.(NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced today that it will report financial results for the third quarter 2024 and business updates after market close onThursday, November 14, 2024.

Company management will host a corresponding conference call beginning at 4:30 p.m. Eastern Time. Investors interested in listening to the conference call may do so by accessing a live and archived webcast of the event atwww.t2biosystems.com, on the Investors page in the Events & Presentations section. To listen to the conference call, please dial 877-545-0320 (US/Canada) or 973-528-0002 (International), passcode 903508, approximately ten to five minutes prior to the start time.

AboutT2 BiosystemsT2 Biosystems, a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, is dedicated to improving patient care and reducing the cost of care by helping clinicians effectively treat patients faster than ever before. T2 Biosystems’ products are powered by the proprietary T2 Magnetic Resonance (T2MR^®) technology and include the T2Dx^®Instrument, the T2Bacteria^®Panel, the T2Candida^®Panel, the T2Resistance^®Panel, and the T2BiothreatTM Panel. T2 Biosystems has an active pipeline of future products, including the U.S. T2Resistance Panel, the T2LymeTM Panel, and the expended T2Candida Panel to add the detection ofCandida auris. For more information, please visitwww.t2biosystems.com.

Investor Contact:Philip Trip Taylor,Gilmartin Groupir@T2Biosystems.com415-937-5406

Source: T2 Biosystems, Inc.

Please be aware that the following content has been generated by an AI system and may contain errors, inconsistencies, or outdated information. It is provided as-is without any warranties or guarantees of accuracy. We strongly recommend using this content as a starting point for further research and consultation with relevant experts or authorities. We disclaim any liability for damages or losses resulting from the use or reliance on this content.Please note that this is a beta version of the Gravity Analytica LLC’s AI Service which isstill undergoing final testing before its official release. Theplatform, its software and all content found on it are provided on an“as is” and “as available” basis. Gravity Analytica LLC does not give any warranties,whether express or implied, as to the suitability or usability of thisservice, webpage, or its software or any of its content.Should you encounter any bugs, glitches, lack of functionality orother problems on the website, please let us know immediately so wecan rectify these accordingly. Your help in this regard is greatlyappreciated! You can write to us at this addressteam@gravityanalytica.com